TrademarkDir
MILLER ADVANCE
LIVE

Serial Number

85784116

Owner

MEDGYN MEDICAL TECHNOLOGIES, INC.

Attorney

Joshua G. Gigger

First Use Date

May 20, 2013

Filing Date

Nov 20, 2012

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MILLER ADVANCE Trademark

Serial Number: 85784116 • Registration: 4744032

MILLER ADVANCE is a trademark filed by MEDGYN MEDICAL TECHNOLOGIES, INC. on November 20, 2012. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

MEDGYN MEDICAL TECHNOLOGIES, INC. (2 trademarks)

800 Pasquinelli Drive
Westmont, IL 60559

Entity Type: 03

Catheter Research, Inc. (8 trademarks)

Indianapolis, IN 46278

Entity Type: 03

MED VENTURE ACQUISITIONS, LLC (2 trademarks)

595 SOUTH RIVERWOODS PARKWAY, SUITE 400
LOGAN, UT 84341

Entity Type: 16

Trademark Details

Filing Date

November 20, 2012

Registration Date

May 26, 2015

First Use Anywhere

May 20, 2013

First Use in Commerce

May 20, 2013

Published for Opposition

December 16, 2014

Goods & Services

catheters; medical devices for use in obstetric and gynecological procedures, namely, catheters and injection devices used for injection of saline or contrast media in conjunction with imaging technology

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 20, 2025 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 20, 2025 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 20, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 20, 2025 APRE
TEAS SECTION 8 & 9 RECEIVED
May 27, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 26, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 24, 2022 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 24, 2022 C15A
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Sep 11, 2021 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 11, 2021 APRE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 9, 2021 ASGN
TEAS SECTION 8 & 15 RECEIVED
May 26, 2021 E815
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 3, 2021 ASCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 27, 2021 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 26, 2020 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 15, 2020 ASCK
REGISTERED-PRINCIPAL REGISTER
May 26, 2015 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 24, 2015 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 23, 2015 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 9, 2015 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 31, 2015 AITU
USE AMENDMENT FILED
Feb 26, 2015 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 26, 2015 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 10, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 16, 2014 NPUB
PUBLISHED FOR OPPOSITION
Dec 16, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 8, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2014 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 6, 2014 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 30, 2014 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 24, 2013 RCSC
ASSIGNED TO LIE
Oct 22, 2013 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 22, 2013 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 22, 2013 GNSL
SUSPENSION LETTER WRITTEN
Apr 22, 2013 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 19, 2013 GNRN
NON-FINAL ACTION E-MAILED
Mar 19, 2013 GNRT
NON-FINAL ACTION WRITTEN
Mar 19, 2013 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 29, 2012 NWOS
NEW APPLICATION ENTERED
Nov 23, 2012 NWAP

Related Trademarks

More from this Owner

CRI logo

CRI

CRI logo

CRI

CRI logo

CRI

DRIVEN TO INNOVATE... FOCUSED ON CARE

DRIVEN TO INNOVATE... FOCUSED ON CARE

DRIVEN TO INNOVATE... FOCUSED ON CARE

DRIVEN TO INNOVATE... FOCUSED ON CARE

DRIVEN TO INNOVATE... FOCUSED ON CARE

DRIVEN TO INNOVATE... FOCUSED ON CARE